Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.41 |
| ▸ | METAP2 | P50579 | 1/20 | 0.40 |
| ▸ | METAP1 | P53582 | 1/20 | 0.40 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.39 |
| ▸ | MARS1 | P56192 | 10/20 | 0.39 |
| ▸ | BHMT | Q93088 | 2/20 | 0.35 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14754348 | 1.00 | RNPEP (0.41) | RNPEPMETAP2METAP1ANPEPENPEP | |
| Sulfur Dioxide SCHEMBL28009863 | 0.96 | RNPEP (0.38) | RNPEPMETAP2METAP1ANPEPENPEP | |
| SCHEMBL27648068 | 0.96 | RNPEP (0.38) | RNPEPMETAP2METAP1ANPEPENPEP | |
| SCHEMBL162031 | 0.89 | RNPEP (0.42) | RNPEPMETAP2METAP1ANPEPENPEP | |
| SCHEMBL20996747 | 0.89 | RNPEP (0.42) | RNPEPMETAP2METAP1ANPEPENPEP | |
| SCHEMBL5617582 | 0.89 | RNPEP (0.42) | RNPEPMETAP2METAP1ANPEPENPEP | |
| SCHEMBL6045793 | 0.89 | RNPEP (0.42) | RNPEPMETAP2METAP1ANPEPENPEP | |
| SCHEMBL28162581 | 0.85 | MARS1 (0.42) | RNPEPMETAP2METAP1ANPEPENPEP | |
| SCHEMBL997468 | 0.84 | RNPEP (0.38) | RNPEPMETAP2METAP1ANPEPENPEP | |
| SCHEMBL1129959 | 0.84 | RNPEP (0.38) | RNPEPMETAP2METAP1ANPEPENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 474 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3218013-B1 | MOLECULAR PROBES FOR DETECTING GRAM-NEGATIVE BACTERIA IN VITRO AND IN VIVO | UNIV COURT UNIV OF EDINBURGH (GB) | 2024-04-17 | — | — | EP | claimed |
| EP-3428140-B1 | PRODUCTION OF IMPROVED FORTIFIER FROM BEER YEAST WATER | ADOBS I INNOVACIO FITOVEGETAL HORTUS NATURA S L (ES) | 2024-03-20 | — | — | EP | claimed |
| EP-4297581-A1 | COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS | Clara Foods Co. (US) | 2024-01-03 | — | — | EP | claimed |
| CN-117295405-A | Composition for preparing animal-free egg products | 克莱拉食品公司 | 2023-12-26 | — | — | CN | claimed |
| EP-3333261-B1 | HEXURONATE C4-EPIMERASE VARIANT WITH IMPROVED D-TAGATOSE PRODUCTION ACTIVITY, AND D-TAGATOSE PRODUCTION METHOD USING SAME | CJ CHEILJEDANG CORP (KR) | 2023-11-15 | — | — | EP | claimed |
| US-20230086338-A1 | COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS | CLARA FOODS CO. | 2023-03-23 | — | — | US | claimed |
| WO-2022182799-A1 | COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS | CLARA FOODS CO. (US) | 2022-09-01 | — | — | WO | claimed |
| EP-3157571-B1 | FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | NOVARTIS AG (CH) | 2021-11-24 | — | — | EP | claimed |
| CN-107073130-B | Fatty acids and their use in conjugation with biomolecules | 诺华股份有限公司 | 2021-11-16 | — | — | CN | claimed |
| EP-2697387-B1 | CHIMERIC ANTIBACTERIAL POLYPEPTIDES | BACTOCLEAR HOLDINGS PTE LTD (SG) | 2021-09-15 | — | — | EP | claimed |
| EP-0739417-B1 | PRODUCTION OF L-ISOLEUCINE BY MEANS OF RECOMBINANT MICRO-ORGANISMS WITH DEREGULATED THREONINE DEHYDRATASE | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2003-09-03 | — | — | EP | claimed |
| EP-0815115-B1 | KERATINOCYTE GROWTH FACTOR-2 | HUMAN GENOME SCIENCES INC (US) | 2003-05-28 | — | — | EP | claimed |
| EP-0754192-B1 | CIRCULARLY PERMUTED LIGANDS AND CIRCULARLY PERMUTED CHIMERIC MOLECULES | US GOV HEALTH & HUMAN SERV (US) | 2003-01-29 | — | — | EP | claimed |
| US-20020192754-A1 | Method for producing active serine proteases and inactive variants | MAX-PLANCK-GESELLSCHAFT E.V. (DE) | 2002-12-19 | — | — | US | claimed |
| EP-0804591-B1 | SERUM PARAOXONASE | HUMAN GENOME SCIENCES INC (US) | 2002-09-25 | — | — | EP | claimed |
| EP-0518587-B1 | A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production | LILLY CO ELI (US) | 1998-05-13 | — | — | EP | claimed |
| EP-0434605-B1 | Novel process for the production of unfused protein in E. coli | CIBA GEIGY AG (CH) | 1996-09-11 | — | — | EP | claimed |
| EP-0319049-B1 | Growth hormone analogs, pharmaceutical and veterinary compositions containing said analogs and methods for production thereof | BIO TECHNOLOGY GENERAL CORP (US) | 1996-04-17 | — | — | EP | claimed |
| EP-0263072-B1 | Novel lymphokine related peptides | CIBA GEIGY AG (CH) | 1994-03-23 | — | — | EP | claimed |
| EP-0077670-B1 | HUMAN IMMUNE INTERFERON | GENENTECH, INC. (US) | 1989-06-28 | — | — | EP | claimed |